Advertisement

Topics

Latest "Virbac Incorporated" News Stories - Page: 4

11:20 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Virbac Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Virbac Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Virbac Incorporated for you to read. Along with our medical data and news we also list Virbac Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Virbac Incorporated Companies for you to search.

Showing "Virbac Incorporated" News Articles 76–100 of 101

Tuesday 10th July 2018

AsiaPacific Brachytherapy Devices Market Segmented by Technique, Application, EndUser and Geography Growth, Trend and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $1922

The AsiaPacific Brachytherapy is expected to register a CAGR of 5.5% during the forecast period, 2018 to 2023. Japan is expected to dominate the market with highest market share followed and India is expected to be the fastest growing market in this region. Brachytherapy related to the implementation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proxi...


Global Regenerative Medicine Market Segmented by Type of Products, Therapy and Applications Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements. Increasing adoption of stem cell technology Increasing adoption of stem cell technology, increasing prevalence of chronic diseases,...

Latin America General Surgical Devices Market Segmented by Product, and Applications Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $3850

The Latin American general surgical devices market is expected to register a CAGR of 7.5% during the forecast period 2018 to 2023. Brazil dominates the market due to growing healthcare expenditure in the region.Increasing Healthcare Expenditures in Latin AmericaLatin America spends a higher share of its GDP on healthcare expenditure. For instance, in 2016, Mexico's healthcare expenditure as a perc...


Global Fruit Spreads Market Growth, Trends, and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

Fruits spreads are made from the processing of fruit juices, and whole fruit, along with/or concentrated form of fruit juice with sugar and pectin. Fruit concentration in spreads can vary from 30% to 60%; spreads are used in baked salad products, dressings, snacks, dessert glaze, breakfast syrups, cake icing, smoothies, etc. The global fruit spreads market was valued at USD 6.83 billion in 2016 an...

Monday 9th July 2018

Global 3D Cell Culture Market Segmented by Technology, Application and EndUser Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global 3D Cell Culture market has been estimated to reach USD 682.8 million in 2017. The market is expected to register a CAGR of 20.3% during the forecast period, 2018 to 2023. North America dominates the market due to the incidence of cancer, and availability of wellestablished pharmaceutical and biotechnology industries. Rising Need for Organ TransplantationCell culture is a process to grow...

Global Feed Additives Market Analysis of Growth, Trends, and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The Global feed additives market is forecasted to register a significant CAGR over the forecast period. Growth in Compound Feed Industry The global compound feed market revenue is estimated to grow at a CAGR of 1.6% over the period 20182023. The compound feed industry is mainly driven by factors like increasing meat consumption across the globe and growth in the processed meat industry due to incr...

Tuesday 3rd July 2018

Virbac : Declaration of the number of shares and voting rights as of June 2018, 30.

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority - Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment BISIN code: FR0000031577 ...

Monday 2nd July 2018

Abzena and Telix sign strategic manufacturing and bioconjugation agreement

    Cambridge, UK and Melbourne, Australia, 2 July 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed GMP manufacturing and bioconjugation agreements with Telix Pharmaceuticals Limited (‘Telix’). The agreements have a comb...

Friday 29th June 2018

Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn

Novartis International AG / Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Alcon strategic review concludes that 100% spinoff in best interest...

Tuesday 19th June 2018

Enamine and TBD Biodiscovery collaborate to provide GMP-based services - Collaboration combines expertise in novel chemical compound synthesis with GMP manufacture in drug discovery

Kiev, Ukraine, and Tartu, Estonia, June 19th 2018. Enamine Ltd., a chemical research organization and producer of novel building blocks and screening libraries, and TBD Biodiscovery, a premium GMP manufacturer of fine chemicals including chemical active pharmaceutical ingredients (APIs), today announced they have entered into a collaboration agreement. The partnership aims to manage the trans...

Thursday 7th June 2018

Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the "Shock and Kill" Approach

Based on a growing body of data demonstrating apabetalone's beneficial attributes as a latency-reversing agent for advancing HIV-1 eradication, Resverlogix is seeking a partner for future development   CALGARY, Alberta and BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Based on recent findings on apabetalone's potential role in human immunodeficiency virus ("HIV-1") eradicat...

Wednesday 6th June 2018

NANOBIOTIX' Management statement on recent share price variation

        NANOBIOTIX' MANAGEMENT STATEMENT ON RECENT SHARE PRICE VARIATION Paris, France and Cambridge, Massachusetts, USA, June 6 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, communicates today regarding the recent evolution of its share price. The Company n...

Tuesday 5th June 2018

Virbac : Declaration of the number of shares and voting rights as of May 2018, 31.

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority - Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment BISIN code: FR0000031577 ...

BioCryst Issues Letter to Stockholders Reiterating Upside Potential of Value-Enhancing Merger with Idera

Powerful IMO-2125 Data from ILLUMINATE-204 Trial Further Supports Value of Combination BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst” or the “Company”), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, today issued an open letter to stockholders in connection with the Company...

Thursday 24th May 2018

Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease

Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained a high percentage of patients with complex coronary artery dis...

Wednesday 16th May 2018

Herbalife Nutrition Announces the Adjusted Price Range of Its Dutch Auction Tender Offer for Common Shares Following Stock-Split

Herbalife Nutrition Ltd. (NYSE: HLF) (“Herbalife Nutrition” or “the Company”) announced today the adjusted price range of its tender offer for Herbalife Nutrition’s common shares, par value $0.0005 per share (“shares”), wherein the Company is seeking to purchase up to $600 million in shares. Following the adjustment to reflect the Company’s ...

Tuesday 15th May 2018

Virbac: Availability of the quarterly financial information as of March 31, 2018

Virbac: Availability of the quarterly financial information as of March 31, 2018 Public release - May 15, 2018 The quarterly financial information as of March 31, 2018 is available: ·           on our website: corporate.virbac.com under the section Investors - Financial reports - 2018;·           or on request, under legal and regulatory conditions. In accorda...

Friday 11th May 2018

Global and China Animal Antimicrobials Sales Market Research by Company, Type Application 20132025 [Report Updated: 09032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Liquid Coating Powder CoatingBy Application Foodproducing Animals Companion AnimalsBy Company Zoetis, Inc. Boehringer Ingelheim GmbH Eli Lilly and Company Merck Co., Inc. Bayer AG Sanofi Ceva Sante Animale Virbac Vetoquinol S.A. Dechra Pharmaceuticals PLCThe main contents of the report including:Section 1:Product d...

Tuesday 8th May 2018

Ligand Reports First Quarter 2018 Financial Results

Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2018, and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement...

Mannatech Reports First Quarter 2018 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2018. First Quarter Results

Friday 4th May 2018

Nicox Provides First Quarter 2018 Business and Financial Results

Press Release Nicox Provides First Quarter 2018 Business  and Financial Results ..............................................   May 4, 2018 - release at 7:30 am CET Sophia Antipolis, France   Nicox SA (

Thursday 3rd May 2018

Teleflex Reports First Quarter 2018 Results

First Quarter Revenues of $587.2 million, up 20.4% Versus Prior Year Period; up 14.6% on Constant Currency Basis First Quarter GAAP Diluted EPS of $1.18, up 35.6% Over the Prior Year Period First Quarter Adjusted Diluted EPS of $2.15, up 19.4% Versus Prior Year Period Raised 2018 Guidance Range for GAAP Revenue Growth from...

Wednesday 2nd May 2018

Virbac : Declaration of the number of shares and voting rights as of April 2018, 30.

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority - Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment BISIN code: FR0000031577 ...

HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board

Southlake, Texas – May 2, 2018 – HeartSciences, a U.S.-based medical device company that is leading innovation in the field of electrocardiology through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced today that Peter W. Macfarlane has joined its board of clinical advisors.  Professor Peter W. Macfarlane, DSc eF...

Friday 27th April 2018

Herbalife Nutrition Announces Extension of Its Tender Offer for Common Shares

Herbalife Nutrition Ltd. (NYSE: HLF) (“Herbalife Nutrition” or “the Company”) announced today it is extending the expiration time of its previously announced tender offer from 5:00 P.M., New York City time, Wednesday, May 16, 2018, to 5:00 P.M., New York City time, Thursday, May 24, 2018, unless the tender offer is further extended. The te...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks